Citations

Mayo Clinic

Clear

45 citation(s) found for "Wada, N W".

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Feldman, Andrew L. , Wada, David A., Lu, Ye , Polk, Avery , Briski, Robert , Ristow, Kay M., Ziesmer, Steven C., Wellik, Linda, Lanigan, Thomas M. , Pittelkow, Mark R. , Bailey, Nathanael G. , Hristov, Alexandra C. , Lim, Megan S. , Ansell, Stephen M. , Wang, Tianjiao , Habermann, Thomas M. , Thomas, Dafydd G. , Witzig, Thomas E. , Wilcox, Ryan A. , Feldman, Andrew L , Lim, Megan S

Blood | February 5, 2014 | Volume: 123 | Issue: 19 | Pages: 3007-3015

10.1182/blood-2013-12-544809 | PMID 24497534 Get It

Key Points Alternatively polarized macrophages are abundant constituents of the tumor microenvironment in T-cell lymphoproliferative disorders. GATA-3 expression identifies a subset of PTCL, NOS with a distinct cytokine profile and inferior survival.
Determination of vagal baroreflex sensitivity in normal subjects
Wada, Naoki , Gehrking, Tonette L., Sletten, David M., Schmelzer, James D., Kihara, Mikihiro, Low, Phillip A. , Singer, Wolfgang

Muscle & Nerve | January 30, 2014 | Volume: 50 | Issue: 4 | Pages: 535-540

10.1002/mus.24191 | PMID 24477673 Get It

ABSTRACTIntroduction: The Valsalva maneuver (VM) is used widely to quantify the sensitivity of the vagal baroreflex loop (vagal baroreflex sensitivity, BRS_v), but most studies have focused on the heart rate (HR) response to blood pressure (BP) decrement (BRS_v↓), even though the subsequent response to an increment in BP after the VM (BRS_v↑) is important and different. Methods: We evaluated recordings of HR and BP in 187 normal subjects during the VM and determined both BRS_v↑, as determined by relating HR to the BP increase after phase III and BRS_v↓. Results: BRS_v↑ was related inversely to age. In addition, BRS_v↓, age, and magnitude of phase IV were independent predictors of BRS_v↑ in a multivariate model, accounting for 47% of the variance of BRS_v↑. Conclusions: The results indicate that both BRS_v↑ and BRS_v↓ become blunted with increasing age and that these indices relate to each other. Muscle Nerve 50: 535–540, 2014
Recognition of Fungal Protease Activities Induces Cellular Activation and Eosinophil-Derived Neurotoxin Release in Human Eosinophils
Matsuwaki, Yoshinori , Wada, Kota, White, Thomas A. , Benson, Linda M., Charlesworth, M. Cristine , Checkel, James L., Inoue, Yoshinari, Hotta, Kyôko, Ponikau, Jens U., Lawrence, Christopher B. , Kita, Hirohito , Charlesworth, M. Cristine , Hotta, Kyoko, Kita, H

The Journal of Immunology | October 29, 2009 | Volume: 183 | Issue: 10 | Pages: 6708-6716

10.4049/jimmunol.0901220 | PMID 19864598 Get It

Abstract Eosinophils are multifunctional leukocytes implicated in the pathogenesis of asthma and in immunity to certain organisms. Associations between exposure to an environmental fungus, such as Alternaria, and asthma have been recognized clinically. Protease-activated receptors (PARs) are G protein-coupled receptors that are cleaved and activated by serine proteases, but their roles in innate immunity remain unknown. We previously found that human eosinophils respond vigorously to Alternaria organisms and to the secretory product(s) of Alternaria with eosinophils releasing their proinflammatory mediators. In this study, we investigated the roles of protease(s) produced by Alternaria and of PARs expressed on eosinophils in their immune responses against fungal organisms. We found that Alternaria alternata produces aspartate protease(s) and that human peripheral blood eosinophils degranulate in response to the cell-free extract of A. alternata. Eosinophils showed an increased intracellular calcium concentration in response to Alternaria that was desensitized by peptide and protease ligands for PAR-2 and inhibited by a PAR-2 antagonistic peptide. Alternaria-derived aspartate protease(s) cleaved PAR-2 to expose neo-ligands; these neo-ligands activated eosinophil degranulation in the absence of proteases. Finally, treatment of Alternaria extract with aspartate protease inhibitors, which are conventionally used for HIV-1 and other microbes, attenuated the eosinophils’ responses to Alternaria. Thus, fungal aspartate protease and eosinophil PAR-2 appear critical for the eosinophils’ innate immune response to certain fungi, suggesting a novel mechanism for pathologic inflammation in asthma and for host-pathogen interaction.
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
Wada, David A., Ziesmer, Steven C., Elsawa, Sherine F. , Comfere, Nneka I. , Dietz, Allan B. , Novak, Anne J. , Feldman, Andrew L. , Pittelkow, Mark R. , Ansell, Stephen M. , Wilcox, Ryan A. , Witzig, Thomas E. , Feldman, Andrew L , Elsawa, Sherine F , Dietz, Allan B

Blood | August 12, 2009 | Volume: 114 | Issue: 14 | Pages: 2936-2944

10.1182/blood-2009-05-220111 | PMID 19671921 Get It

A variety of nonmalignant cells present in the tumor microenvironment promotes tumorigenesis by stimulating tumor cell growth and metastasis or suppressing host immunity. The role of such stromal cells in T-cell lymphoproliferative disorders is incompletely understood. Monocyte-derived cells (MDCs), including professional antigen-presenting cells such as dendritic cells (DCs), play a central role in T-cell biology. Here, we provide evidence that monocytes promote the survival of malignant T cells and demonstrate that MDCs are abundant within the tumor microenvironment of T cell–derived lymphomas. Malignant T cells were observed to remain viable during in vitro culture with autologous monocytes, but cell death was significantly increased after monocyte depletion. Furthermore, monocytes prevent the induction of cell death in T-cell lymphoma lines in response to either serum starvation or doxorubicin, and promote the engraftment of these cells in nonobese diabetic/severe combined immunodeficient mice. Monocytes are actively recruited to the tumor microenvironment by CCL5 (RANTES), where their differentiation into mature DCs is impaired by tumor-derived interleukin-10. Collectively, the data presented demonstrate a previously undescribed role for monocytes in T-cell lymphoproliferative disorders.
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Feldman, Andrew L. , Wada, David A., Yang, Zhi‐Zhang, Comfere, Nneka I. , Dong, Haidong , Kwon, Eugene D., Novak, Anne J. , Pittelkow, Mark R. , Ansell, Stephen M. , Wilcox, Ryan A. , Markovic, Svetomir N. , Witzig, Thomas E. , Feldman, Andrew L , Dong, Haidong

Blood | July 14, 2009 | Volume: 114 | Issue: 10 | Pages: 2149-2158

10.1182/blood-2009-04-216671 | PMID 19597183 Get It

AbstractStromal elements present within the tumor microenvironment may suppress host immunity and promote the growth of malignant lymphocytes in B cell–derived non-Hodgkin lymphoma (NHL). In contrast, little is known about the microenvironment's role in T cell–derived NHL. B7-H1 (PD-L1, CD274), a member of the B7 family of costimulatory/coinhibitory ligands expressed by both malignant cells and stromal cells within the tumor microenvironment, has emerged as an important immune modulator capable of suppressing host immunity. Therefore, B7-H1 expression and function were analyzed in cutaneous and peripheral T-cell NHL. B7-H1 was expressed by tumor cells, monocytes, and monocyte-derived cells within the tumor microenvironment in T-cell NHL and was found to inhibit T-cell proliferation and promote the induction of FoxP3+ regulatory T cells. Collectively, the data presented provide the first evidence implicating B7-H1 in the suppression of host immunity in T-cell lymphoproliferative disorders and suggest that the targeting of B7-H1 may represent a novel therapeutic approach.